Platinum chemotherapy aged the liver cells of treated children, making them look more like adult liver cells and possibly ...

The pharma industry invested billions of dollars to develop drugs heralded as the next era in the treatment of heart disease ...

A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall ...

UniQure readout tests durability of benefits, an AI effort to manage heart failure, and more biotech news from The Readout ...

Before the end of September, UniQure is expected to report four-year results from the closely tracked clinical trial of its ...

A Roivant lung disease drug has succeeded in a mid-stage study. But the drug’s origins are another fascinating aspect to the ...

There has been rancorous debate over doctors accepting free gifts and speaking fees from pharma companies. That doesn't mean ...

The two measles-related deaths in Pennsylvania last month involved infants, and the virus itself caused one of the deaths, a ...

A U.K. commission has unveiled its recommendations for how the country should regulate artificial intelligence in medicine.

Rural health care providers, which have struggled for years, are facing nearly $1 trillion in Medicaid cuts over the coming ...

Feds invest in AI for heart failure, vaccines and this year's midterms, and more health news from Morning Rounds ...

Nothing in the recent reporting about John Fetterman is medically surprising,” write Michael P.H. Stanley and Isaiah Kletenik.